AKT1 and colorectal carcinoma: applied specific sgRNA to block its expression in CRC cell lines and showed that CRISPR/Cas9-mediated LSD1 ablation corresponded to inhibition of AKT-induced epithelial–mesenchymal transition (EMT) and migration [129].